Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tinzaparin Effect on Inflammatory Biomarkers in Acute DVT
NCT04741464Active, not recruiting
- Sponsor
- CHU Amiens-Picardie
- Start
- Feb 2021
- Primary completion
- Nov 2023
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Open-label, single-arm trial of tinzaparin in deep vein thrombosis (DVT), sponsored by CHU Amiens-Picardie. Primary endpoint: I-CAM levels variation in acute DVT patient at 1 year. Started Feb 2021; status: active, not recruiting.
02
Drugs
tinzaparin
03
Conditions
deep vein thrombosis (DVT)
Beyond the preview
Go deeper on NCT04741464.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04741464.